Johnson & Johnson names selection committee for Dr. Paul Janssen Award for Biomedical Research

NEW BRUNSWICK, N.J., Sept. 12, 2005 -- Johnson & Johnson today announced the appointment of a top-level scientific committee of international experts who will serve as the selection committee to nominate and select the inaugural recipient of the Dr. Paul Janssen Award for Biomedical Research. The Award was created to honor Dr. Paul Janssen, or "Dr. Paul" as he was known throughout the scientific community, one of the 20th century's most gifted and passionate scientists who revolutionized modern medicine and inspired a new generation of researchers. At the time of his death in 2003, Dr. Paul's work had produced more than 80 medicines that helped save millions of lives. In addition, he was the founder of Janssen Pharmaceutica, which later became part of the Johnson & Johnson family of companies.

The Award selection committee, nominated by Dr. Per Peterson, chairman, research & development, pharmaceutical group at Johnson & Johnson, Dr. Harlan Weisman, company group chairman, research & development, pharmaceuticals at Johnson & Johnson, and Dr. Theodore Torphy, corporate vice president, science and technology at Johnson & Johnson, includes:

  • Dr. Arvid Carlsson (Sweden), University of Gothenburg, Sweden, 2000 Nobel Laureate in Physiology or Medicine
  • Dr. Jean Marie Lehn (France), professor, College de France, 1987 Nobel Laureate in Chemistry.
  • Dr. Hartmut Michel (Germany), director, department of Molecular Membrane Biology, University of Frankfurt, 1988 Nobel Laureate in Chemistry.
  • Dr. Edward Scolnick (United States), former president of Merck Research Laboratories, Merck and Company, now director of the Psychiatry Initiative at the Broad Institute, member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the Institute of Medicine.
  • Dr. Sol Snyder (United States), professor and director of the Department of Neuroscience at Johns Hopkins School of Medicine, 1978 co-winner of the Albert La

Contact: Mark Krajnak
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Page: 1 2 3

Related biology news :

1. Gladstones Deepak Srivastava receives E. Mead Johnson Award for achievement in pediatrics
2. Johnson & Johnson announces call for nominations
3. VIB and Johnson & Johnson set up a new fund
4. HSPHs Walter Willett wins Bristol-Myers Squibb/Mead Johnson Freedom to Discover Award
5. Conservation International and SC Johnson partner again to offset carbon impacts
6. Saudi Arabias KAUST names WHOI first research partner
7. Norwegian council names ASU researcher Outstanding Young Investigator
8. Damon Runyon names new class of rising stars in cancer research
9. APS names UC Davis professor Bodil Schmidt-Nielsen Distinguished Mentor and Scientist
10. Scientific American names UCSB professor, alumna to list of Top 50 in Technological Leadership
11. Biophysical Society names 2007 award recipients

Post Your Comments:

(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: